The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Links

 

Gene Review

Amfr  -  autocrine motility factor receptor

Mus musculus

Synonyms: AMF receptor, Autocrine motility factor receptor, E3 ubiquitin-protein ligase AMFR, gp78
 
 
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.
 

Disease relevance of Amfr

 

High impact information on Amfr

 

Biological context of Amfr

  • The cells stably expressing high levels of AMFR as a result of transfection displayed a complete morphological change and acquired the ability to grow even in low serum [1].
  • Our findings provide a direct evidence that overexpression of the AMFR is associated with the acquisition of a transformation phenotype [1].
  • On the other hand, AMF receptor activation induced significant decrease in overall serine-phosphorylation level of cellular proteins accompanied by serine phosphorylation of 200, 90, 78 and 65 kd proteins [7].
 

Anatomical context of Amfr

 

Associations of Amfr with chemical compounds

 

Other interactions of Amfr

  • However, alpha-MSH did neither prevent the secretion of AMF from B16-BL6 cells nor alter the expression level of AMF receptor (gp78) [8].

References

  1. Overexpression of autocrine motility factor receptor (AMFR) in NIH3T3 fibroblasts induces cell transformation. Onishi, Y., Tsukada, K., Yokota, J., Raz, A. Clin. Exp. Metastasis (2003) [Pubmed]
  2. Expression of autocrine motility factor receptor in serum- and protein-independent fibrosarcoma cells: implications for autonomy in tumor-cell motility and metastasis. Watanabe, H., Shinozaki, T., Raz, A., Chigira, M. Int. J. Cancer (1993) [Pubmed]
  3. Regulation of melanoma-cell motility by the lipoxygenase metabolite 12-(S)-HETE. Timar, J., Silletti, S., Bazaz, R., Raz, A., Honn, K.V. Int. J. Cancer (1993) [Pubmed]
  4. Purification of B16-F1 melanoma autocrine motility factor and its receptor. Silletti, S., Watanabe, H., Hogan, V., Nabi, I.R., Raz, A. Cancer Res. (1991) [Pubmed]
  5. Caveolin-1 is a negative regulator of caveolae-mediated endocytosis to the endoplasmic reticulum. Le, P.U., Guay, G., Altschuler, Y., Nabi, I.R. J. Biol. Chem. (2002) [Pubmed]
  6. Tumor autocrine motility factor responses are mediated through cell contact and focal adhesion rearrangement in the absence of new tyrosine phosphorylation in metastatic cells. Silletti, S., Paku, S., Raz, A. Am. J. Pathol. (1996) [Pubmed]
  7. Autocrine motility factor (neuroleukin, phosphohexose isomerase) induces cell movement through 12-lipoxygenase-dependent tyrosine phosphorylation and serine dephosphorylation events. Timár, J., Tóth, S., Tóvári, J., Paku, S., Raz, A. Clin. Exp. Metastasis (1999) [Pubmed]
  8. Induction of autocrine factor inhibiting cell motility from murine B16-BL6 melanoma cells by alpha-melanocyte stimulating hormone. Murata, J., Ayukawa, K., Ogasawara, M., Watanabe, H., Saiki, I. Int. J. Cancer (1999) [Pubmed]
 
WikiGenes - Universities